OcuLight TX Laser Console 32000-4Recalls & reported problems
Iridex Corporation · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00813125016494), received between Dec 17, 2025 and Dec 17, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Electrical /Electronic Property Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Electrical /Electronic Property Problem1
Patient problems
- Eye Injury1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryDec 17, 2025Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
IRIDEX BECAME AWARE OF AN INCIDENT INVOLVING OCULIGHT TX LASER CONSOLE AND SLIT LAMP ADAPTER (SLA) WERE THE LASER OUTPUT WAS TOO HIGH AND CAUSED BLEEDING AT PATIENT'S EYE. THE TREATMENT SETTING AND TECHNIQUE USED DURING THE PROCEDURE WAS SET TO 200MW. THE PATIENT DID NOT HAVE ANY SIGNIFICANT MEDICAL HISTORY. THE PATIENT WAS UNAWARE OF THE BLEEDING AND THE DOCTOR IMMEDIATELY STOPPED THE TREATMENT UPON REALIZING THERE WAS A MINOR BLEED. THE PATIENT WAS GIVEN AN EYEDROP AFTER THE PROCEDURE AND DID NOT REPORT ANY FURTHER COMPLICATIONS. THE UNIT WAS NOT RETURNED FOR EVALUATION, HOWEVER UPON SERVICE INVESTIGATION IT WAS DETERMINED THAT THE ISSUE WAS CAUSED BY A BURNT FIBER. FIBER REPLACEMENT WAS SENT TO THE CUSTOMER. THE REPORTED EVENT DUE TO A BURNT FIBER IS A KNOWN RISK/FAILURE MODE. THE OCULIGHT TX CONSOLE OPERATOR MANUAL CLEARLY INSTRUCTS ON THE PHYSICIAN VERIFY THAT THE FIBER-OPTIC CONNECTOR IS NOT DAMAGED BEFORE USE AS WELL AS THE PRE-SET PARAMETER SETTINGS BEGINNING AT LOW POWER WITH SHORT DURATION EXPOSURES, THE SURGEON SHOULD NOTE THE SURGICAL EFFECT AND INCREASE POWER, POWER DENSITY, OR EXPOSURE DURATION UNTIL THE DESIRED SURGICAL EFFECT IS OBTAINED. THE OPERATIVE NEEDS OF EACH
Patient problems: Eye Injury
MAUDE report 23830744 ↗
Other Powered Laser Surgical Instrument devices
- Moxy 0010-2400Boston Scientific Corporation · Powered Laser Surgical Instrument4,572 reports
- SOLTIVE TFL-PLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls450 reports
- Flexiva TracTip M0068403960Boston Scientific Corporation · Powered laser surgical instrument562 reports
- Moses™ AC-10030100Lumenis Ltd. · Powered Laser Surgical Instrument532 reports
- Flexiva M0068403910Boston Scientific Corporation · Powered laser surgical instrument376 reports
- Visualase 9735542Medtronic Navigation, Inc. · Powered laser surgical instrument1 recall2 deaths311 reports
- SOLTIVE TFL-SLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls33 reports
- NeuroBlate® System 20980Monteris Medical Inc · Powered laser surgical instrument7 deaths296 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page